top of page

ASCO & EHA 2023 - Many Exciting Cancer Presentations Coming

First published 5/5/23


  • The American Society of Clinical Oncology Annual Meeting is taking place from June 2-6, 2023

  • The European Hematology Association Annual Meeting is taking place from June 8-11, 2023

  • There are many important dates coming for these two conferences as well as exciting presentations coming in June

  • See our full forum post to see which companies are presenting new data at ASCO 2023 and watch for our EHA 2023 forum coming next week!


See a full list of ASCO presentations with our FREE email download!


Important Dates:

ASCO (Titles released April 26)

  • Abstracts release May 25th 5pm ET

  • Late breaking abstracts release 7am CT on day of presentation

  • Embargo policy: once abstracts release the embargo is lifted - additional press released can be distributed containing full data, including data even if wasn't in the abstract

  • Conference dates: June 3-6


  • Abstracts release May 11

  • Late breaking abstracts release June 1

  • Embargo policy: Embargo is lifted on the first day of conference

  • Conference dates: June 8-11

Top indications at ASCO:

  • 5 companies presenting from NSCLC trials

  • 5 companies presenting from Breast cancer trials

  • 4 companies presenting from Ovarian cancer trials

Some exciting ASCO presentations:

  • ONCY Overall survival data from Ph2 breast cancer BRACELET-1 study

  • IMAB ORR data from Ph2 NSCLC study

  • DAWN Additional Phase 2 FIREFLY-1 data

  • PDSB Ph2 VERSATILE-002 updated data

See Table 1 for a list of smid-cap biopharmas presenting at ASCO 2023 from June 2-6, 2023. See our full forum post to see which companies are presenting new data at ASCO 2023. Keep an eye out for our EHA tables coming after abstracts are released (May 11).

Watch for EHA presentations coming next week!

Table 1. Smid-cap biopharma companies presenting at ASCO 2023

See our full forum post to see which companies are presenting new data at ASCO 2023.

This list may include many companies of interest to investors, especially because these companies may see bigger stock changes on release of abstracts since the embargo will be lifted and press releases can be distributed by companies, even including additional data not in the abstracts!

EHA abstracts are coming next week, and we will likely see big stock moves from these companies when the embargo is lifted on the first day of the conference.


If you are serious about investing in biotech stocks BPIQ is the research companion that will take you to the next level.

Save yourself time by accessing our database of over 550 companies, 1,800+ of their drug assets, and tools including: Catalyst Calendar, Big Movers, Company Pipelines, and more!


See what our members are saying about us:

Mike from United States

“Really loving the site over the competitor... like the layout and speed over the the individual pages for each drug/treatment”

Carl from United States

“I like your service. I haven’t seen anyone else doing something similar...nothing like this available for retail.”

Essey from Canada

“Love what you’re doing, this website is awesome.”

James from United States

Great site and I see it’s a family run business, great job.”



bottom of page